PITPNM3 and breast cancer: Additional studies have shown that CCL18-induced breast cancer metastasis occurs through the Pyk2 receptor, Pyk2 N-terminal domain interacting receptor 1 (Nir1), and that Nir1 expression is associated with lymph nodes and distant metastasis in patients with invasive breast cancer [62].